Casein Kinase I<i>γ</i>2 Impairs Fibroblasts Actin Stress Fibers Formation and Delays Cell Cycle Progression in G1

Latreille, Mathieu; Abu-Thuraia, Afnan; Oliva, Rossella; Zuo, Dongmei; Larose, Louise

doi:https://doi.org/10.1155/2012/684684

International Journal of Cell Biology

On this page

Abstract Introduction Materials and Methods Results Discussion Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2012 | Article ID 684684 | https://doi.org/10.1155/2012/684684

Casein Kinase Iγ2 Impairs Fibroblasts Actin Stress Fibers Formation and Delays Cell Cycle Progression in G1

Mathieu Latreille,¹Afnan Abu-Thuraia,¹Rossella Oliva,¹Dongmei Zuo,¹and Louise Larose¹

Academic Editor: Liza Pon

Received06 Sept 2011

Revised01 Dec 2011

Accepted05 Dec 2011

Published07 Mar 2012

Abstract

Actin cytoskeleton remodeling is under the regulation of multiple proteins with various activities. Here, we demonstrate that the γ2 isoform of Casein Kinase I (CKIγ2) is part of a novel molecular path regulating the formation of actin stress fibers. We show that overexpression of CKIγ2 in fibroblasts alters cell morphology by impairing actin stress fibers formation. We demonstrate that this is concomitant with increased phosphorylation of the CDK inhibitor and lower levels of activated RhoA, and is dependent on CKIγ2 catalytic activity. Moreover, we report that roscovitine, a potent inhibitor of cyclin-dependent kinases, including Cdk5, decreases protein levels and restores actin stress fibers formation in CKIγ2 overexpressing cells, suggesting the existence of a CKIγ2-Cdk5--RhoA pathway in regulating actin remodeling. On the other hand, we also show that in a manner independent of its catalytic activity, CKIγ2 delays cell cycle progression through G1. Collectively our findings reveal that CKIγ2 is a novel player in the control of actin cytoskeleton dynamics and cell proliferation.

1. Introduction

The Rho family of GTPases comprising RhoA, Rac1, and Cdc42 regulates the organization of the cytoskeleton in eukaryotic cells [1]. These proteins cycle between an active GTP-bound and inactive GDP-bound state through the action of GTPase exchange factors (GEFs) and GTPase activating proteins (GAPs) [2]. Once activated, RhoA regulates actin stress fibers formation [3], while Rac1 triggers the assembly of actin in lamellipodia and membrane ruffles [4] and Cdc42 induces filopodial extensions [5] at the leading edge of the cell. Over the years, Rho GTPases were found to be crucial regulators of actin remodeling involved in a great deal of normal cellular functions, including cell migration and adhesion, cell cycle progression, and membrane trafficking [6]. In addition, Rho GTPases contribute to pathological conditions, particularly to cancer initiation and metastasis by controlling cell proliferation, migration, and adhesion during oncogenic transformation [7–9].

Accumulating evidence suggests that Rho GTPases are regulated at least in part by the cyclin-dependent kinase inhibitors (CDKIs) , , and through different mechanisms. As example, , which depends on its abundance and nuclear localization to inhibit the cyclin-dependent kinases (CDKs), inhibits RhoA activation in a cell-cycle independent manner, thereby modulates actin dynamics [10]. In fact, phosphorylation at Ser10 increases its stability and cytoplasmic localization [11, 12], where it binds to and inhibits RhoA by interfering with the interaction between RhoA and its activating GEFs [10]. Among protein kinases that regulate , cyclin-dependent kinase 5 (Cdk5), also known as a regulator of actin dynamics, was found to stabilize through phosphorylation of at Ser10 in cortical neurons [13]. However, whether Cdk5 possesses similar activity in nonneuronal cells remains to be determined.

Casein kinase I (CKI) encompass a large family of Ser/Thr protein kinases encoded by separate genes and several splice variants. The 7 mammalian CKI isoforms identified so far, namely, α, β, γ1–3, δ, and ε, share high degree of identity within their kinase domain, but differ significantly in the length and amino acid composition of their N- and C-termini [14]. Overall, CKIs are conserved throughout evolution and involved in diverse cellular functions [15]. CKIα, δ, and ε involved in vesicular trafficking [16–18] are also implicated in canonical Wnt signaling, but with distinct role [19]. CKIδ transduces specific centrosome functions [20], but, like CKIε, it also contributes to the regulation of the circadian rhythm [21, 22], apoptosis [23], and neuronal neurite outgrowth [24]. Interestingly, among the CKI family, the closely related CKIγ proteins (CKIγ1, 2, and 3) are unique in carrying C-terminal lipid modification motif that is believed to anchor them at the plasma membrane [25, 26]. In agreement with CKIγ plasma membrane localization, expression of the Xenopus tropicalis CKIγ in vertebrates and Drosophila cells has been implicated in transducing early signaling events of LRP6, a cell surface membrane receptor involved in Wnt signaling [25]. However, very little is known regarding the function of individual mammalian CKIγ isoforms. Previously, we reported that the Src homology (SH) domain-containing adaptor protein Nck directly interacts with CKIγ2 through two of its SH3 domains [27], while we determined that a proline rich motif (P³⁴³DVPSQPR³⁵²) unique to the C-terminal noncatalytic tail of CKIγ2 is mediating binding of Nck (unpublished data). Given that Nck transduces signals from membrane receptor protein tyrosine kinases to effectors regulating crucial biological cellular responses such as actin cytoskeletal reorganization and cell proliferation, we further investigated CKIγ2 function in mammalian cells.

In this study, we provide evidence that the kinase activity is required for CKIγ2 to regulate actin cytoskeleton remodeling through its ability to downregulate RhoA proteins and signaling via the activation of the Cdk5- pathway. In addition, our findings also reveal that in a manner independent of its catalytic activity, CKIγ2 also regulates cell proliferation.

2. Materials and Methods

2.1. CKIγ Constructs

The mouse CKIγ1, 2, and 3 full length cDNAs were subcloned downstream of a Kozak sequence and in frame with a HA epitope sequence into the mammalian expression vector pZeoSV2 (Invitrogen). A kinase deficient (KD) CKIγ2 full length cDNA was generated by introducing a point mutation (K⁷⁵R) in the ATP-binding site. A cDNA (1–1020 nts) encompassing the kinase domain, but lacking the C-terminal extension of CKIγ2 (Δ C-term), was generated by PCR using appropriate specific primers and further subcloned into pZeoSV2 as reported above. All constructs were fully sequenced to confirm their identity and to ensure that no unwanted mutation had been introduced during their creation.

2.2. Stable Cell Lines of Fibroblast Overexpressing CKIγ2

Rat-2 fibroblasts were cultured in DMEM (Dulbecco’s modified Eagle’s medium; Life Technologies, Inc) supplemented with 2 mM L-glutamine, 45 mM sodium bicarbonate, and 10% FBS at 37°C, in a humidified atmosphere of 95% air and 5% CO₂. Using calcium phosphate precipitation, fibroblasts were transfected with indicated expression plasmids. Upon selection in medium containing high concentration of zeocin (500 μg/mL) or G418 (400 μg/mL) for cells transfected, respectively, with pZeoSV2 or pcDNA 3.1, individual clones were isolated, grown, and analyzed for expected proteins expression. Positive clones were propagated under the same conditions, except that 50 μg/mL zeocin or 40 μg/mL G418 was added to the culture medium. For fibroblasts transfected with the empty pZeoSV2 plasmid, instead of individual clones following zeocin selection procedure, a pool of resistant cells was propagated and used as control.

2.3. Cell Culture and Transient Transfection

Rat-2 and HaCaT cells were grown in DMEM and HepG2 cells in Minimum Essential Medium Alpha Medium (MEM) (Invitrogen) supplemented with antibiotic/antimycotic (Invitrogen) and 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen) at 37°C in 5% CO₂/95% O₂. For CKIγ1, 2, and 3 transient expression into Rat-2 cells, cells plated at 80% confluency in 60 mm dishes were transiently transfected with indicated expression plasmids using Lipofectamine-Plus reagent (Invitrogen) according to the manufacturer’s instructions.

2.4. SiRNA Transfection

Human CK1γ2 siRNAs targeting two independent coding regions (R1 and R2) were purchased from Integrated DNA technologies (IDT) R1(5′-GCACCUGGAGUACCGGUUC-3′) and R2(5′-GCGCUACAUGAGCAUCAAC-3′). Scrambled siRNA obtained also from IDT was used as control. HepG2 and HaCaT cells were transiently transfected with indicated siRNA using Lipofectamine RNAiMAX reagent (Invitrogen) according to the manufacturer’s instructions. Briefly, 300 μmol of siRNA was added to 500 μL of Opti-MEM I Medium without serum (Invitrogen) in 6-well plates and mixed gently. 5 μL of Lipofectamine RNAiMAX reagent was added to each well containing diluted siRNAs, mixed gently, and incubated at room temperature for 20 min. In the meantime, cells were harvested, counted, and diluted at 200 000 cells/mL in MEM media without antibiotics. Then, 2.5 mL of cells suspension (i.e., 500 000 cells/well) were added to each well and mixed gently, making the final siRNA concentration at 100 nM. The cells were further incubated at 37°C for 48–72 hours.

2.5. Antibodies, Immunoprecipitation, and Western Blots

To immunoprecipitate HA-tagged CKIγ2, we used the commercial HA F-7 antibody (Santa Cruz). For western blot analysis, the following antibodies were used: HA Y-11 (Santa Cruz); p53 FL-393 (Santa Cruz), Nck 1794 (in house [27]), C-10 (Santa Cruz); C-19 (Santa Cruz) and RhoA F-1 (Santa Cruz). To detect CKIγ2, we generated a rabbit polyclonal antibody using a KHL-coupled CKIγ2 peptide encompassing aa 331–354 as antigen. In general, cells were lysed in lysis buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 10% Glycerol, 1% Triton X-100, 1.5 mM MgCl₂, 1 mM EGTA, 10 mM sodium pyrophosphate, 10 mM sodium fluoride) supplemented with 2 μg/mL leupeptin and aprotinin as well as with 1 mM phenyl-methylsulfonyl fluoride (PMSF) and 200 μM activated sodium orthovanadate. Clarified cell lysates were normalized to equal protein concentrations with the lysis buffer and protein immunoprecipitations performed using appropriate antibodies. Immune complexes were subsequently collected with Protein A-Agarose (SantaCruz), and, after several washes with the lysis buffer, proteins were eluted in Laemmli buffer [28], boiled, and subjected to SDS-PAGE. Western Blots were performed as previously described [29] using chemiluminescence (ECL Plus, GE Healthcare, UK). When mentioned, equal amounts of total cell proteins were subjected to SDS-PAGE and subjected to Western Blot analysis following the same protocol.

2.6. In Vitro Kinase Assays

Immunoprecipitated proteins immobilized on Protein A beads or recombinant GST fusion proteins were washed five times with lysis buffer and three times with the kinase buffer before being divided in two aliquots, which were, respectively, subjected to in vitro kinase assay and immunoblot. For CKI activity, the kinase buffer was composed of 20 mM Hepes, pH 7.5, 1 mM dithiothreitol (DTT), 5 mM MgCl₂, 10 mM β-glycerophosphate, and 5 μg of α-casein as exogenous substrate. For all assays, following a preincubation at 30°C for 5 min, the reactions were initiated by adding [γ-³²P]-ATP (50 μM, 5–10 μCi) (DuPont, NEN) and further incubated for 20 min at 30°C. The reactions were stopped by adding Laemmli buffer, boiled, subjected to SDS-PAGE and then to autoradiography. Phosphorylation of exogenous substrates was analyzed by densitometry (Imaging Densitometer, Model GS-800, BioRad). To assess whether CKIγ2 phosphorylates RhoA in vitro, 200 ng of purified recombinant GSTCKIγ2 full length (FL) or truncated of its C-terminal ( C-term) were incubated with 1 μg of purified recombinant RhoA as reported above.

2.7. Cell Proliferation

Proliferation of stable fibroblast cell lines was evaluated by counting the number of cells, different times after plating. Cells were seeded at 5 × 10³ cells/60 mm plate, in triplicate for each time points and cell lines. On days 3, 5, and 7 after plating, the cells were trypsinized and counted using a hemocytometer.

2.8. ³H-Thymidine Incorporation

Cells were plated at 2 × 10⁴cells/well in 24 wells plates and grown for 24 hours in DMEM containing 10% FBS. The next day, the cells were starved for 36 hours in DMEM supplemented with 0.1% BSA. At the end of the starvation period, the medium was replaced by fresh starving medium with or without FBS at 2.5% or PDGF at 25 ng/mL and the cells incubated for an additional 24 hours. During the last 8 hours of stimulation, 0.5 μCi of ³H-Thymidine was added. Thymidine incorporation was stopped by replacing the medium by cold TCA (10%) and further incubation at 4°C. Precipitated material was then solubilized in 0.3 N NaOH and incorporated ³H-Thymidine counted by liquid scintillation using a LKB 1219 Rack Beta Liquid scintillation Counter.

2.9. DNA Laddering

Following washes with PBS, serum growing cells in culture dishes were directly lyzed in 0.5 mL of DNAzol genomic isolation reagent (Molecular Research Center, Inc., Cincinnati, OH). The resulting lysates were subjected to repeated pipetting and DNA precipitation performed by adding 0.25 mL of 100% ethanol. Samples were mixed by inverting the tubes 5–8 times and kept at room temperature for 3 min. Precipitated DNA was then spooled using a pipette tip, washed twice in 70% ethanol, and dissolved in water. Samples of total DNA were separated on 1.8% agarose gel and stained with ethidium bromide. As positive control, primary rat thymocytes maintained in culture in DMEM supplemented with 10% FBS were treated with 10 μg/mL of anisomycin for 24 hours. Thymocytes were collected by centrifugation, washed with PBS and genomic DNA prepared as described above.

2.10. Cell Cycle Analysis

For flow cytometry analysis (FACS), 1 × 10⁶ of serum growing cells were collected, fixed in 70% ethanol following incubation for 15 min on ice and storage for at least 1 hour at −20°C. Fixed cells were washed in cold PBS, and stained with propidium iodide (PI, Sigma) using a solution containing 50 μg/mL of PI and 10 μg/mL of RNAse in PBS at 37°C for 30 min. Quantification of cell populations in different phases of the cell cycle was determined using the Cell Quest software (Becton Dickinson, CA).

2.11. Cell Morphology and Actin Staining

Cells plated on coverslips were rinsed with PBS before being fixed for 10 min at room temperature in 4% formaldehyde/PBS. Following fixation, coverslips were rinsed with PBS and the cells permeabilized in 0.2% Triton X-100/PBS for 5 min at room temperature. For filamentous actin staining, cells were incubated with rhodamine-conjugated phalloidin (0.1 μg/mL; Sigma, Oakville, ON. Canada) or phalloidin-coupled to Alexa Fluor 488Fluor for 30–60 min at room temperature. For HA-staining, we used the commercially available anti-HA 12CA5 (Roche Apllied Science). Coverslips were washed with PBS and water prior to being mounted with Mowiol and examined on a Zeiss Axiovert 200 microscope at 40X or 63X using Zeiss oil immersion. Fluorescence images were subsequently captured using a digital camera (DVC) and analyzed with Northern Eclipse software (Empix Imaging Inc.). Images were transferred to Adobe Photoshop and assembled with PowerPoint.

2.12. Rho Activation Assays

Essentially, levels of activated RhoA (RhoA-GTP) were assessed using the Rho activation kit purchased from Millipore (cat. no. 17–294). Briefly, serum growing fibroblasts (R2Zeo and Z23), about 70% confluent, were transiently transfected with a vector-encoding Myc-tagged RhoA (100 ng) using Lipofectamine Plus (Invitrogen). Cells lysates prepared 16 hours after transfection were mixed with 60 μg of recombinant GST-Rhotekin Rho binding domain previously isolated on beads. Following 45 min at 4°C, beads were washed three times, boiled in Laemmli sample buffer, and bound proteins separated on a 12% SDS-polyacrylamide gel. Levels of Myc-tagged RhoA proteins bound to the fusion protein or present in the whole cell lysates were evaluated by western blotting with a rabbit polyclonal anti-Rho antibody (RhoA, B, and C) provided with the kit and ECL Plus detection as reported above.

2.13. Cells Stimulation

Cells (6 × 10⁴) were plated on coverslips 24 hours prior to be serum starved for 24 hours in DMEM/0.1% BSA and subsequently treated with 50 ng/mL of lysophosphatidic acid (LPA, Sigma) for 30 min at 37°C or overnight. For roscovitine experiments, we treated the cells overnight with 25 μM roscovitine (Sigma). Control cells were exposed to equivalent volume of vehicle. Cells were then washed, stained for filamentous actin using phalloidin and mounted for immunofluorescence microscopy or processed for western blot analysis as previously described.

3. Results

3.1. CKIγ2 Overexpression in Fibroblasts Alters Cell Morphology and Inhibits Actin Stress Fibers Formation in a Kinase-Dependent Manner

To investigate the role of CKIγ2 in mammalian cells, we generated fibroblasts that stably overexpress CKIγ2 by transfecting a plasmid encoding N-terminal HA-tagged wild-type CKIγ2 [29]. Fibroblasts transfected with an empty plasmid are considered as control. We selected a pool of empty plasmid transfected cells (R2Zeo) as control and three independent clones expressing different levels of the 50–55 kda HACKIγ2 protein () to further study (Figure 1(a)). We demonstrated the activity of HA-CKIγ2 by performing in vitro kinase assays on HA immunoprecipitates (IP) using α-casein as exogenous substrate (Figure 1(b)). Visual examination of these cells foremost revealed that fibroblasts overexpressing higher levels of CKIγ2 (Z6 and Z23) presented marked change of morphology when compared with fibroblasts overexpressing lower levels of CKIγ2 (A20) or mock-transfected fibroblasts (R2Zeo) (Figure 1(c)). We observed that cells harboring higher levels of CKIγ2 (Z6 and Z23) lost their fibroblastic elongated shape to acquire a more rounded morphology. Actin staining with phalloidin demonstrated that the rounded shrunken morphology of these cells (Z6 and Z23) is associated with a drastic decrease in actin stress fibers (Figure 1(d)).

(a)

(b)

(c)

(d)

Figure 1

CKIγ2 overexpression in fibroblasts alters cell morphology and actin stress fibers formation. (a) Isolated clones of fibroblasts stably transfected with a plasmid encoding HA-tagged-CKIγ2 (A20, Z6, and Z23) or pool of stable cells transfected with an empty plasmid (R2Zeo) were analyzed for HA-CKIγ2 expression by Western Blot (WB) on HA immunoprecipitates (IP). (b) CKIγ2 activity determined on HA immunoprecipitates in in vitro kinase assays using phosphorylation of exogenous α-casein. (c) Indicated serum growing cells were analyzed for cell morphology by phase contrast microscopy (40X) and (d) actin organization using rhodamine-conjugated phalloidin staining (63X). R2Zeo: control; A20, Z6, and Z23: clones overexpressing increasing levels of CKIγ2.

To assess whether loss of actin stress fibers in fibroblasts overexpressing CKIγ2 affects cell motility, we compared the migratory activity of fibroblasts overexpressing CKIγ2 (Z23) with control fibroblasts (R2Zeo) using in vitro wound healing assays. To ensure that cells in the wounded area result from cell motility, rather than proliferation, fibroblasts were deprived from serum for 24 hours prior to performing the wound. As shown in Figure 2, fibroblasts that overexpress CKIγ2 did not migrate and fill the wounded area at a rate comparable to control fibroblasts. Altogether, these observations indicate that overexpression of CKIγ2 in fibroblasts induces dissolution of actin stress fibers and impairs cell motility in vitro.

We next investigate whether the kinase activity is required for CKIγ2 to inhibit the formation of actin stress fibers. For this, we generated two independent clones of fibroblasts stably overexpressing a kinase deficient form of CKIγ2 (KD1, KD30) at levels almost comparable to wild-type CKIγ2 levels detected in the Z23 cell line (Figure 3(a), upper panel). As expected, CKIγ2 KD (K75R) is devoid of catalytic activity as shown by the absence of α-casein phosphorylation in HA-immunoprecipitated CKIγ2 KD in in vitro kinase assays (Figure 3(a), lower panel). However, we observed similar to control cells (R2Zeo) morphology and levels of actin stress fibers organization in fibroblasts overexpressing kinase deficient CKIγ2 (KD) (Figure 3(b)). This demonstrates that the kinase activity of CKIγ2 is required for the inhibition of actin stress fibers formation.

(a)

(b)

Figure 3

The catalytic activity of CKIγ2 is required to induce change in cell morphology and actin stress fibers in fibroblasts. (a) Isolated clones of fibroblasts stably transfected with a plasmid encoding HA-tagged wild-type CKIγ2 (Z23), HA-tagged kinase deficient CKIγ2 (KD1 and KD30), or pool of stable fibroblasts transfected with an empty plasmid (R2Zeo) were analyzed for HA-CKIγ2 expression by HA Western Blot (WB) on HA immunoprecipitates (IP) and CKIγ2 activity as determined on HA immunoprecipitates from equal amounts of protein normalized cell lysates and in vitro kinase assays using α-casein as substrate. KD1 and KD30: clones that overexpress kinase deficient CKIγ2 at the same levels as cells stably overexpressing wild-type CKIγ2 (Z23). (b) Morphology of serum growing cells was visualized by phase contrast microscopy (40X) (upper panels) and actin organization by actin staining with rhodamine-conjugated phalloidin (63X) (lower panels).

To demonstrate that the regulation of actin stress fiber formation by CKIγ2 occurs not only in overexpressing conditions, we assessed actin stress fibers in HaCaT human keratinocytes transiently transfected with two siRNAs (R1, R2) derived from short hairpin-type RNA constructs targeting independent coding regions of hCKIγ2 that have been reported to effectively downregulate CKIγ2 in these cells [30]. As shown in Figure 4, HaCaT cells treated with CKIγ2 siRNAs substantially present increased formation of stress fibers, supporting a physiological role for CKIγ2 in regulating actin cytoskeleton reorganization.

3.2. CKIγ2 Overexpression in Fibroblasts Decreases RhoA Protein and RhoA-GTP Levels

Formation of actin stress fibers is under the control of the small GTPases Rho [3]; therefore, we first compared the levels of RhoA protein in fibroblasts overexpressing CKIγ2 with control fibroblasts (Figure 5(a)). Interestingly, we found that overexpression of CKIγ2 results in decreased levels of the RhoA proteins, suggesting that dissolution of actin stress fibers in CKIγ2 overexpressing fibroblasts might be due to low levels of RhoA proteins that yield to nonefficient RhoA signaling activity. To further investigate this point, we expressed Myc-RhoA in fibroblasts overexpressing or not CKIγ2 and determined the levels of active Myc-RhoA-GTP by measuring the amount of Myc-RhoA proteins bound by a GST fusion protein encoding the Rho-binding domain of Rhotekin. Consistent with decreased actin stress fibers and lower RhoA protein levels in fibroblasts overexpressing CKIγ2, we found lower levels of activated RhoA (Myc-RhoA-GTP) as well as total Myc-RhoA in cells overexpressing higher levels of CKIγ2 (Figure 5(b)). To further support that increased expression of CKIγ2 downregulates RhoA protein levels, we transiently transfected Rat-2 fibroblast with increasing amounts of plasmid encoding HA-CKIγ2 and assessed expression levels of HA-CKIγ2 and RhoA in total cell lysates by western blotting. In agreement with decreased levels of RhoA protein in fibroblasts overexpressing high levels of CKIγ2 (Z23), transient expression of high levels of CKIγ2 leads to lower levels of RhoA protein (Figure 5(c)). Altogether, these data suggest that CKIγ2 contributes to lowering the expression or enhancing the degradation of RhoA and this could result in attenuated RhoA signaling.

(a)

(b)

(c)

Figure 5

Overexpression of CKIγ2 in fibroblasts reduces the levels of RhoA protein and RhoA activation. (a) Fibroblasts stably overexpressing CKIγ2 (Z23) and control fibroblasts (R2Zeo) were analyzed for RhoA protein expression levels by Western Blot using equivalent amount of total cell lysate proteins. (b) Levels of activated Myc-RhoA (Myc-RhoA-GTP) were assessed following transient expression of MycRhoA in serum growing fibroblasts control (R2Zeo) or overexpressing CKIγ2 (Z23) using pull down of equivalent amount of total cell lysate proteins with a GST fusion protein encoding the Rho-binding domain of Rhotekin. (c) Total cell lysates from fibroblasts transiently transfected with increasing amount of plasmid encoding HA-CKIγ2 were subjected to Western Blot analysis with indicated antibodies.

To determine whether fibroblasts overexpressing CKIγ2 can still be challenged by external stimuli to build up actin stress fibers, we treated these cells with the serum-borne phospholipid lysophosphatidic acid (LPA), a G-protein-coupled receptor agonist which regulates the assembly of actin stress fibers through the activation of RhoA [31]. Actin staining of fibroblasts expressing high levels of HA-CKIγ2 in response to LPA stimulation at 50 ng/mL for 10–30 min revealed that, in all conditions, LPA treatment results in formation of actin stress fibers (Figure 6(a)). Finally, actin stress fibers could be rescued by expressing a constitutively active RhoA (RhoAL63) in fibroblasts overexpressing CKIγ2. Altogether, these data suggest that signaling downstream of RhoA is intact in fibroblasts overexpressing CKIγ2 and it also could be efficiently challenged to lead to the formation of actin stress fibers (Figure 6(b)). Overall, our observations provide strong evidence supporting that CKIγ2-mediated inhibition of RhoA-dependent formation of actin stress fibers is reversible and could result from impaired expression and activation of the GTPases Rho.

(a)

(b)

Figure 6

LPA stimulation and activated RhoA rescue actin stress fibers formation in fibroblasts overexpressing CKIγ2. (a) Actin staining following LPA stimulation (50 ng/mL, 10–30 minutes, and 37°C) in serum-starved fibroblasts control (R2Zeo) or stably overexpressing CKIγ2 (Z6 and Z23). Pictures were taken at 63X. (b) Myc, Actin, and DAPI staining of CKIγ2 overexpressing fibroblasts (Z23) transiently transfected with a cDNA encoding a constitutively activate form of RhoA (Myc-RhoA L63). Pictures were taken at 40X.

3.3. RhoA Is Not Phosphorylated by CKIγ2 In Vitro

As serine phosphorylation of Rho proteins negatively regulates their activity, we determined whether CKIγ2 could directly phosphorylate RhoA in vitro. For this, we incubated GST fusion protein encoding CKIγ2 full length (FL) or truncated with its noncatalytic C-terminal domain deleted ( C-term), with recombinant RhoA in presence of [γ-³²P] ATP and assessed ³²P labeling of RhoA upon SDS-PAGE and autoradiography. As shown in Figure 7, CKIγ2 full length and CKIγ2 deleted of its C-terminal domain autophosphorylate in vitro, suggesting that these are active protein kinases. In contrast, RhoA was not phosphorylated by either GST-CKIγ2 constructs, suggesting that in vivo CKγ2 does not induce actin stress fibers disassembly by directly phosphorylating and inhibiting RhoA.

3.4. CKIγ2 Overexpression in Fibroblasts Inhibits Cell Proliferation and Delays Cell Cycle Progression in G1

In addition to the effect of overexpressing CKIγ2 on cell morphology, we found that fibroblasts overexpressing CKIγ2 proliferate at a significant slower rate compared with control fibroblasts (Figure 8(a)). In addition, decreased proliferation appears to correlate with the extent of CKIγ2 overexpression. Diminished proliferation in cells overexpressing CKIγ2 was further confirmed by decreased incorporation of ³H-thymidine into DNA in response to PDGF, a potent mitogenic factor for fibroblast [32], or serum over a 24-hour period of stimulation (Figure 8(b)). For an unknown reason, incorporation of ³H-thymidine in response to PDGF or serum stimulation in fibroblasts overexpressing higher levels of CKIγ2 (Z6 and Z23) is often decreased compared with their respective unstimulated basal levels (Z6: Bas , PDGF , FBS ; Z23: Bas , PDGF , FBS cpm). Therefore, to exclude cell death as an important factor contributing to decreased proliferation, all cell lines were subjected to DNA laddering assay (Figure 8(c)) and DAPI staining (data not shown). As a positive control for DNA laddering, we used primary cultured rat thymocytes treated for 24 hours with anisomycin (10 ug/mL). Using both approaches, we established that apoptosis is not responsible for the apparent decrease in proliferation of cells overexpressing CKIγ2. In agreement, significant increase in doubling time calculated from growth curves for all aforementioned cell lines overexpressing CKIγ2 compared with control fibroblasts suggests that overexpression of CKIγ2 increases cell cycle duration (Table 1). To test this hypothesis, we performed FACS analysis to determine the distribution of actively serum growing asynchronized cells stably overexpressing CKIγ2 throughout the different phases of the cell cycle. As reported in Table 2, 50% of control fibroblasts mock-transfected were detected in G1 and the remaining cell population was evenly distributed into S and G2 phases (approximately 23%, resp.). In contrast, fibroblasts overexpressing CKIγ2 presented a significant larger population of cells in G1 (63–70%) and a reduced percentage of cells in S and G2 phases (12–17%). Collectively, these results indicate that CKIγ2 inhibits cell proliferation by modulating cell cycle progression through G1.

Figure 8

CKIγ2 overexpression in fibroblasts reduces cell proliferation. (a) Cell proliferation was examined by seeding each cell line in triplicate at 3 × 10⁵ cells/60 mm plate on day 0. On days 3, 5, and 7, cells were trypsinized and counted. Results are expressed as the average ± SEM of three independent experiments and for Z6 and Z23, the symbols include the SEM. *Significantly different at least at as determined by Student’s -test when compared with R2Zeo cells. (b) Incorporation of ³H-thymidine in response to PDGF (25 ng/mL) or serum (2.5% FBS) stimulation was performed in indicated cell lines. Results are expressed as the fold of thymidine incorporation in presence of PDGF or FBS over basal unstimulated condition and are the mean ± SEM of three independent experiments performed in quadruplicate. *Significantly different at least at as determined by Student’s -test compared with respective basal condition. (c) Indicated serum growing cells were submitted to DNA laddering assays according to standard procedures described in Materials and Methods. As positive control for apoptosis, primary rat thymocytes in culture were exposed 24 hours to anisomycin (10 μg/mL).

3.5. Overexpression of CKIγ2 in Fibroblasts Increases Expression of the CDK Inhibitors and and the Tumor Suppressor p53

Consistent with a larger population of cells in G1 and reduced thymidine incorporation into DNA during the S phase of the cell cycle, earlier G1 phase cell cycle events could account for the antiproliferative effect of CKIγ2. To address this, we then compared the expression of the CDKIs and and the tumor suppressor p53 in fibroblasts overexpressing CKIγ2 with control fibroblasts. Our investigation revealed that inhibition of cell proliferation and delay in cell cycle progression in fibroblasts overexpressing CKIγ2 correlate with increased expression of , , and p53 (Figure 9(a)). Surprisingly, the effects of CKIγ2 on cell cycle regulators are independent of its catalytic activity as shown in fibroblasts overexpressing CKIγ2 kinase dead (KD1 and 30) (Figure 3) that still shows increased expression of , and p53 proteins. This is in contrast with the effects of CKIγ2 on actin reorganization that require the catalytic activity of CKIγ2 (Figure 3). Interestingly, increased expression of and appear, to be CKIγ2 dosage independent compared to increased expression of p53 which correlates with the levels of CKIγ2 overexpressed (Figures 9(a) and 9(b)). Overall, these findings demonstrate that CKIγ2 impairs cell proliferation by delaying cells in the G1 phase of the cell cycle. Likewise, the fact that fibroblasts overexpressing CKIγ2 are still evenly distributed in S and G2 phases of the cell cycle suggests that these steps proceed normally and that the effects of CKIγ2 on cell proliferation are restricted to the G1 phase of the cell cycle.

(a)

(b)

To further demonstrate a role for CKIγ2 on expression levels of CDK inhibitors, we compared protein expression levels between HepG2 cells transfected with CKIγ2 specific siRNAs and scramble siRNA (Figure 10). Using this approach, we found that efficient downregulation of CKIγ2 in HepG2 cells leads to decreased expression of proteins.

CKIγ2 is closely related to CKIγ1 and 3, and, like CKI γ2, CKIγ1 and 3 are believed to also be membrane associated due to a putative palmitoylation site present in their C-terminus [25]. In attempt to determine to what extend the effects of CKIγ2 on and actin stress fiber are isoform specific, we failed to establish stable fibroblast cell lines overexpressing CKIγ1 or 3, most likely due to toxicity as reported by others [33]. This was also the case for transient overexpression of CKIγ1 in fibroblasts, while transient overexpression of CKIγ2 or γ3 was possible. Therefore, we carried out transient transfection of fibroblasts with an empty plasmid as control, or plasmid encoding either HA-tagged CKIγ2 or γ3 and monitored levels and actin organization using these cells (Figure 11). As reported above, expression of HA-tagged CKIγ2 or γ3 was detected using total cell lysates in Western Blot with anti-HA antibody (Figure 11(a)). Interestingly, as observed in stable cell lines overexpressing CKIγ2, transient overexpression of CKIγ2 increases protein levels. However, this is also observed in fibroblasts overexpressing CKIγ3 (Figure 11(a)). More importantly, transient overexpression of either CKIγ2 or CKIγ3 negatively impacts actin stress fibers formation (Figure 11(b)). These results suggest that, like CKI2, CKIγ3 could also regulate the expression of CDK inhibitors and actin cytoskeleton reorganization, at least when overexpressed.

(a)

(b)

Figure 11

Overexpression of either CKIγ2 or CKIγ3 in fibroblasts increases expression of and inhibits formation of actin stress fibers. (a) Fibroblasts transiently transfected with plasmids encoding either HA-CKIγ2 or HA-CKIγ3 were analyzed for HA-tagged proteins and protein expression levels by Western Blot. The arrow represents HA-CKIγ2 or HA-CKIγ3, while nonspecific bands are indicated by asterisks. Actin was used as loading control. (b) Similar fibroblasts were stained for HA or actin organization using phalloidin coupled to AlexaFluor 488. Arrows indicate HA-positive cells, while arrow heads point nontransfected cells. Pictures were taken at 63X.

3.6. Inhibition of Roscovitine-Sensitive Cyclin-Dependent Kinases Reduces the Level of and Rescues Actin Stress Fibers Formation in Fibroblasts Overexpressing CKIγ2

Since phosphorylation of at Ser10 increases its stability and cytoplasmic accumulation [11, 12] where it can bind and inhibit RhoA [10], we first determined whether phosphorylation at Ser10 was increased in fibroblasts overexpressing CKIγ2. Indeed, we found that the level of phosphorylated at Ser10 was higher in CKIγ2 overexpressing than in control fibroblasts (Figure 12(a)). In addition, we found that roscovitine, a potent inhibitor of cyclin-dependent kinases with good selectivity toward Cdk1, Cck2, Cdk5, Cdk7, and Cdk9 [34], not only strongly reduced the levels of proteins (Figure 12(b)), but also rescued actin stress fibers formation in fibroblasts overexpressing CKIγ2 (Figure 12(c)). Interestingly, we observed that Cdk5, a roscovitine sensitive cyclin-dependent kinase that is phosphorylated and activated by CKI [35–37] and known to affect actin dynamics by interacting and phosphorylating at Ser¹⁰ [13], is equally expressed in fibroblasts independently of CKIγ2 expression levels (Figure 12(a)). Collectively our findings indicate an important role for CKIγ2 in modulating actin dynamics through a Cdks- pathway, potentially implicating Cdk5.

Figure 12

Roscovitine reverses the effects of CKIγ2 overexpression on and actin stress fibers. (a) From indicated cell lines, equivalent amount of total cell lysate proteins was subjected to Western Blot analysis using specific antibodies against total and phospho-Ser¹⁰ , Cdk5, and HA. β-Actin was used as loading control. (b) Equivalent amount of total cell lysate proteins from indicated cells treated or not with roscovitine that were subjected to Western Blot analysis using specific antibodies against or β-actin was used as loading control. (c) Cells overexpressing CKIγ2 were incubated with roscovitine (25 μM, 16 hrs) before to be stained with phalloidin to visualized actin organization. Images were taken at 63X.

4. Discussion

In this study, we provide evidence that the isoform γ2 of CKI prevents the formation of actin stress fibers and delays cell cycle progression in G1. We showed that CKIγ2 induces phosphorylation and accumulation of and decreases expression levels of RhoA, which could result in inadequate levels of activated RhoA to sustain actin stress fibers formation in fibroblasts expressing higher levels of CKIγ2. Moreover, we demonstrate that the effects of CKIγ2 on and actin stress fibers are dependent on a subset of Cdks. The findings that CKI regulates Cdk5 activity [35–37] and that Cdk5 is expressed in fibroblasts suggest that the effects of CKIγ2 on actin dynamics in fibroblasts overexpressing CKIγ2 potentially implicate activation of Cdk5. Several studies indicated that Cdk5 affects actin remodeling in neuronal cells [13, 38–41]. In addition, recent evidence point to a critical role of Cdk5 in the regulation of stability and cytoplasmic retention by directly phosphorylating on Ser10 [13]. Interestingly, a role for in the regulation of RhoA activation [10] has been reported. Indeed, directly interacts with RhoA, inhibiting RhoA activation by interfering with RhoGEFs. Therefore, these findings are consistent with our model suggesting that CKIγ2 regulates actin remodeling through a Cdk5--RhoA pathway (Figure 13).

Figure 13

Model describing how CKIγ2 prevents the formation of actin stress fibers and regulates cell proliferation. Overexpression of CKIγ2 activates Cdk5, which contributes to stabilization and cytoplasmic accumulation following phosphorylation of at Ser¹⁰. Increased cytoplasmic level of correlates with decreased cellular levels of RhoA. also inhibits RhoA activation by directly binding to RhoA and competing RhoA interaction with RhoGEFs. Reduced RhoA signaling then results in decreased formation of stress fibers. Roscovitine rescues RhoA activation and signaling by inhibiting CKIγ2-induced activation of Cdk5 therefore prevents phosphorylation at Ser¹⁰ and promotes degradation. (1) indicates CKIγ2 kinase-independent, while (2) represents CKIγ2 kinase-dependent.

The yeast homologs of the mammalian CKIγ isoforms (Yck1/2, Cki1⁺/2⁺) [26] have been implicated in various biological functions. In S. cerevisiae, independent loss of function of the YCK1 and YCK2 genes did not alter growth, but simultaneous loss of function of both genes resulted in lethality [42]. This established the YCK genes as an essential genes pair. In contrast, in S. pombe, gene disruption experiments showed that neither cki1⁺ nor cki2⁺ is essential for cell viability [43]. However, overexpression of cki2⁺, but not cki1⁺, resulted in growth inhibition accompanied by aberrant morphology. This suggests that, despite overall similarity in structure, high homology in amino acids sequence and probable overlap in substrate specificity, close related isoforms might have non overlapping functions and play distinct role in cells.

In this study, we showed that CKIγ2 stably overexpressed in fibroblast, alters cell morphology and formation of actin stress fibers concomitant with lower levels of activated RhoA, a small GTPase that regulates actin stress fibers formation in response to growth factors [3]. Interestingly, actin stress fibers were restored by directly activating RhoA signaling following LPA treatment or expression of a constitutively active RhoA, suggesting that CKIγ2 regulates upstream events leading to RhoA expression and activation. Meanwhile, we also found that CKIγ2 increases expression of the tumor suppressor p53 and the CDK inhibitors and and negatively regulates cell proliferation by delaying cell progression through G1. To explain poor proliferation of CKIγ2 overexpressing fibroblasts, we propose that level of RhoA activity in these cells is too low to efficiently counteract the induction of the CDK inhibitors and promote adequate timing of expression of the cyclin D1, both processes normally under the control of RhoA [44–46]. Interestingly, Cdk5 activation in neuronal cells occurs only in postmitotic neurons [47], suggesting that, in fibroblasts overexpressing CKIγ2, modulation of the cell cycle resulting in decreased mitotic activity may precede and be required for the activation of Cdk5 by CKIγ2. Although additional experiments are required to investigate this point, here we propose a model in which CKIγ2 induces the activation of Cdk5 in a kinase-dependent manner to promote cytoplasmic accumulation of the CDK inhibitor that prevents RhoA activation and leads to inhibition of actin stress fibers formation (Figure 13). In summary, this study contributes to improve our knowledge of molecular mechanisms regulating the activity of critical proteins governing actin cytoskeleton dynamics.

Acknowledgments

This study received funding from the Canadian Institutes of Health Research (Grant no. MT-15643) and the Canadian Diabetes Association.

References

A. Hall, “Rho GTpases and the actin cytoskeleton,” Science, vol. 279, no. 5350, pp. 509–514, 1998.
View at: Publisher Site | Google Scholar
A. Schmidt and A. Hall, “Guanine nucleotide exchange factors for Rho GTPases: turning on the switch,” Genes and Development, vol. 16, no. 13, pp. 1587–1609, 2002.
View at: Publisher Site | Google Scholar
A. J. Ridley and A. Hall, “The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors,” Cell, vol. 70, no. 3, pp. 389–399, 1992.
View at: Publisher Site | Google Scholar
A. J. Ridley, H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall, “The small GTP-binding protein rac regulates growth factor-induced membrane ruffling,” Cell, vol. 70, no. 3, pp. 401–410, 1992.
View at: Publisher Site | Google Scholar
R. Kozma, S. Ahmed, A. Best, and L. Lim, “The ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts,” Molecular and Cellular Biology, vol. 15, no. 4, pp. 1942–1952, 1995.
View at: Google Scholar
L. Van Aelst and C. D'Souza-Schorey, “Rho GTPases and signaling networks,” Genes and Development, vol. 11, no. 18, pp. 2295–2322, 1997.
View at: Google Scholar
R. G. Qiu, A. Abo, F. McCormick, and M. Symons, “Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation,” Molecular and Cellular Biology, vol. 17, no. 6, pp. 3449–3458, 1997.
View at: Google Scholar
R. G. Qiu, J. Chen, F. Mccormick, and M. Symons, “A role for Rho in Ras transformation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 25, pp. 11781–11785, 1995.
View at: Publisher Site | Google Scholar
R. G. Qiu, J. Chen, D. Kirn, F. McCormick, and M. Symons, “An essential role for Rac in Ras transformation,” Nature, vol. 374, no. 6521, pp. 457–459, 1995.
View at: Google Scholar
A. Besson, M. Gurian-West, A. Schmidt, A. Hall, and J. M. Roberts, “p27Kip1 modulates cell migration through the regulation of RhoA activation,” Genes and Development, vol. 18, no. 8, pp. 862–876, 2004.
View at: Publisher Site | Google Scholar
G. Rodier, A. Montagnoli, L. Di Marcotullio et al., “p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis,” EMBO Journal, vol. 20, no. 23, pp. 6672–6682, 2001.
View at: Publisher Site | Google Scholar
N. Ishida, M. Kitagawa, S. Hatakeyama, and K. I. Nakayama, “Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability,” Journal of Biological Chemistry, vol. 275, no. 33, pp. 25146–25154, 2000.
View at: Publisher Site | Google Scholar
T. Kawauchi, K. Chihama, Y. I. Nabeshima, and M. Hoshino, “Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration,” Nature Cell Biology, vol. 8, no. 1, pp. 17–26, 2006.
View at: Publisher Site | Google Scholar
U. Knippschild, A. Gocht, S. Wolff, N. Huber, J. Löhler, and M. Stöter, “The casein kinase 1 family: participation in multiple cellular processes in eukaryotes,” Cellular Signalling, vol. 17, no. 6, pp. 675–689, 2005.
View at: Publisher Site | Google Scholar
J. K. Cheong and D. M. Virshup, “Casein kinase 1: complexity in the family,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 4, pp. 465–469, 2011.
View at: Publisher Site | Google Scholar
L. Behrend, D. M. Milne, M. Stöter et al., “IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects,” Oncogene, vol. 19, no. 47, pp. 5303–5313, 2000.
View at: Google Scholar
S. D. Gross, D. P. Hoffman, P. L. Fisette, P. Baas, and R. A. Anderson, “A phosphatidylinositol 4,5-bisphosphate-sensitive casein kinase Iα associates with synaptic vesicles and phosphorylates a subset of vesicle proteins,” Journal of Cell Biology, vol. 130, no. 3, pp. 711–724, 1995.
View at: Publisher Site | Google Scholar
K. Ikeda, O. Zhapparova, I. Brodsky et al., “CK1 activates minus-end-directed transport of membrane organelles along microtubules,” Molecular Biology of the Cell, vol. 22, no. 8, pp. 1321–1329, 2011.
View at: Publisher Site | Google Scholar
B. del Valle-Pérez, O. Arqués, M. Vinyoles, A. G. de Herreros, and M. Duñach, “Coordinated action of CK1 isoforms in canonical Wnt signaling,” Molecular and Cellular Biology, vol. 31, no. 14, pp. 2877–2888, 2011.
View at: Publisher Site | Google Scholar
Y. E. Greer and J. S. Rubin, “Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth,” Journal of Cell Biology, vol. 192, no. 6, pp. 993–1004, 2011.
View at: Publisher Site | Google Scholar
M. Akashi, Y. Tsuchiya, T. Yoshino, and E. Nishida, “Control of intracellular dynamics of mammalian period proteins by casein kinase I ε (CKIε) and CKIδ in cultured cells,” Molecular and Cellular Biology, vol. 22, no. 6, pp. 1693–1703, 2002.
View at: Publisher Site | Google Scholar
Q. J. Meng, E. S. Maywood, D. A. Bechtold et al., “Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 34, pp. 15240–15245, 2010.
View at: Publisher Site | Google Scholar
J. K. Cheong, N. T. Hung, H. Wang et al., “IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation,” Oncogene, vol. 30, no. 22, pp. 2558–2569, 2011.
View at: Publisher Site | Google Scholar
J. Bischof, A. Müller, M. Fänder, U. Knippschild, and D. Fischer, “Neurite outgrowth of mature retinal ganglion cells and PC12 cells requires activity of CK1δ and CK1ε,” PLoS One, vol. 6, no. 6, Article ID e20857, 2011.
View at: Publisher Site | Google Scholar
G. Davidson, W. Wu, J. Shen et al., “Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction,” Nature, vol. 438, no. 7069, pp. 867–872, 2005.
View at: Publisher Site | Google Scholar
L. Zhai, P. R. Graves, L. C. Robinson et al., “Casein kinase Iγ subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes,” Journal of Biological Chemistry, vol. 270, no. 21, pp. 12717–12724, 1995.
View at: Publisher Site | Google Scholar
G. Lussier and L. Larose, “A casein kinase I activity is constitutively associated with Nck,” Journal of Biological Chemistry, vol. 272, no. 5, pp. 2688–2694, 1997.
View at: Publisher Site | Google Scholar
U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970.
View at: Publisher Site | Google Scholar
E. B. Bioukar, N. C. Marricco, D. Zuo, and L. Larose, “Serine phosphorylation of the ligand-activated β-platelet-derived growth factor receptor by casein kinase I-γ2 inhibits the receptor's autophosphorylating activity,” Journal of Biological Chemistry, vol. 274, no. 30, pp. 21457–21463, 1999.
View at: Publisher Site | Google Scholar
X. Guo, D. S. Waddell, W. Wang et al., “Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling,” Oncogene, vol. 27, no. 58, pp. 7235–7247, 2008.
View at: Publisher Site | Google Scholar
W. H. Moolenaar, O. Kranenburg, F. R. Postma, and G. C. M. Zondag, “Lysophosphatidic acid: G-protein signalling and cellular responses,” Current Opinion in Cell Biology, vol. 9, no. 2, pp. 168–173, 1997.
View at: Publisher Site | Google Scholar
C. D. Scher, R. C. Shepard, H. N. Antoniades, and C. D. Stiles, “Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle,” Biochimica et Biophysica Acta, vol. 560, no. 2, pp. 217–241, 1979.
View at: Google Scholar
T. Dubois, P. Kerai, E. Zemlickova et al., “Casein kinase I associates with members of the centaurin-α family of phosphatidylinositol-(3,4,5)-trisphosphate-binding proteins,” Journal of Biological Chemistry, vol. 276, no. 22, pp. 18757–18764, 2001.
View at: Publisher Site | Google Scholar
S. Bach, M. Knockaert, J. Reinhardt et al., “Roscovitine targets, protein kinases and pyridoxal kinase,” Journal of Biological Chemistry, vol. 280, no. 35, pp. 31208–31219, 2005.
View at: Publisher Site | Google Scholar
P. C. Chen, C. L. Lao, and J. C. Chen, “The D3 dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5,” Journal of Neurochemistry, vol. 110, no. 4, pp. 1180–1190, 2009.
View at: Publisher Site | Google Scholar
F. Liu, X. H. Ma, J. Ule et al., “Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11062–11068, 2001.
View at: Publisher Site | Google Scholar
P. Sharma, M. Sharma, N. D. Amin, R. W. Albers, and H. C. Pant, “Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11156–11160, 1999.
View at: Publisher Site | Google Scholar
A. K. Fu and N. Y. Ip, “Cyclin-dependent kinase 5 links extracellular cues to actin cytoskeleton during dendritic spine development,” Cell adhesion & migration, vol. 1, no. 2, pp. 110–112, 2007.
View at: Google Scholar
F. Qiao, C. Y. Gao, B. K. Tripathi, and P. S. Zelenka, “Distinct functions of Cdk5(Y15) phosphorylation and Cdk5 activity in stress fiber formation and organization,” Experimental Cell Research, vol. 314, no. 19, pp. 3542–3550, 2008.
View at: Publisher Site | Google Scholar
F. Roselli, P. Livrea, and O. F. X. Almeida, “Cdk5 is essential for soluble amyloid β-Induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton,” PLoS One, vol. 6, no. 7, Article ID e23097, 2011.
View at: Publisher Site | Google Scholar
D. Smith, “Cdk5 in neuroskeletal dynamics,” NeuroSignals, vol. 12, no. 4-5, pp. 239–251, 2003.
View at: Publisher Site | Google Scholar
L. C. Robinson, E. J. A. Hubbard, P. R. Graves et al., “Yeast casein kinase I homologues: an essential gene pair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 1, pp. 28–32, 1992.
View at: Google Scholar
P. C. Wang, A. Vancura, A. Desai, G. Carmel, and J. Kuret, “Cytoplasmic forms of fission yeast casein kinase-1 associate primarily with the particulate fraction of the cell,” Journal of Biological Chemistry, vol. 269, no. 16, pp. 12014–12023, 1994.
View at: Google Scholar
M. Liberto, D. Cobrinik, and A. Minden, “Rho regulates p21CIP1, cyclin D1, and checkpoint control in mammary epithelial cells,” Oncogene, vol. 21, no. 10, pp. 1590–1599, 2002.
View at: Publisher Site | Google Scholar
C. J. Marshall, “Small GTPases and cell cycle regulation,” Biochemical Society Transactions, vol. 27, no. 4, pp. 363–370, 1999.
View at: Google Scholar
M. F. Olson, A. Ashworth, and A. Hall, “An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1,” Science, vol. 269, no. 5228, pp. 1270–1272, 1995.
View at: Google Scholar
L. H. Tsai, T. Takahashi, V. S. Caviness Jr., and E. Harlow, “Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system,” Development, vol. 119, no. 4, pp. 1029–1040, 1993.
View at: Google Scholar

Copyright

Copyright © 2012 Mathieu Latreille et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2385

Downloads

2228

Citations

International Journal of Cell Biology

Casein Kinase Iγ2 Impairs Fibroblasts Actin Stress Fibers Formation and Delays Cell Cycle Progression in G1

Abstract

1. Introduction

2. Materials and Methods

2.1. CKIγ Constructs

2.2. Stable Cell Lines of Fibroblast Overexpressing CKIγ2

2.3. Cell Culture and Transient Transfection

2.4. SiRNA Transfection

2.5. Antibodies, Immunoprecipitation, and Western Blots

2.6. In Vitro Kinase Assays

2.7. Cell Proliferation

2.8. 3H-Thymidine Incorporation

2.9. DNA Laddering

2.10. Cell Cycle Analysis

2.11. Cell Morphology and Actin Staining

2.12. Rho Activation Assays

2.13. Cells Stimulation

3. Results

3.1. CKIγ2 Overexpression in Fibroblasts Alters Cell Morphology and Inhibits Actin Stress Fibers Formation in a Kinase-Dependent Manner

3.2. CKIγ2 Overexpression in Fibroblasts Decreases RhoA Protein and RhoA-GTP Levels

3.3. RhoA Is Not Phosphorylated by CKIγ2 In Vitro

3.4. CKIγ2 Overexpression in Fibroblasts Inhibits Cell Proliferation and Delays Cell Cycle Progression in G1

3.5. Overexpression of CKIγ2 in Fibroblasts Increases Expression of the CDK Inhibitors and and the Tumor Suppressor p53

3.6. Inhibition of Roscovitine-Sensitive Cyclin-Dependent Kinases Reduces the Level of and Rescues Actin Stress Fibers Formation in Fibroblasts Overexpressing CKIγ2

4. Discussion

Acknowledgments

References

Copyright

2.8. ³H-Thymidine Incorporation